Embolic Device Articles & Analysis
15 news found
” APEX-AV is a single-arm Investigational Device Exemption study that enrolled 122 patients with confirmed acute, intermediate-risk PE across 25 hospital-based sites in the United States. ...
Haggstrom brings an extensive background in medical device commercialization and product launches, with a technical background in R&D engineering, holding over 20 U.S. patents. ...
Most recently, he was President and CEO of Keystone Heart, a structural heart medical device company, and creator of the first Cerebral Embolic Protection device designed to provide complete coverage to all brain regions for patients undergoing cardiac procedures. ...
BySafeHeal
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, and thrombosis currently associated with IVC filters. ...
The LOBO occluders integrate patented HDBRAID® technology and an innovative design to provide interventional physicians with a One-and-Done solution for embolization. The highly occlusive braided structure rapidly reduces flow and enables single-device occlusions of blood vessels throughout the body. ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results as of and for the second quarter ended June 30, 2021. ...
With experiments in extreme environments such as high altitude and free diving, these scientists are using our device to better understand compromised lung function due to disease processes. ...
Ramirez, an emergency physician in Toronto, “By using the device (AGM100), we are sending fewer patients to the Intensive Care Unit, and we have higher confidence that those sent to the ICU really need to be there. ...
“LOBO-3 and LOBO-5, to be followed by LOBO-7 and LOBO-9, are designed and built to enable fast, predictable and complete occlusion of a diverse set of vascular targets without the need for multiple embolic devices.” About Okami Medical Okami Medical, Inc. is a privately-held medical device company with a mission to address the ...
Patients wear a small clip on their nose while breathing normally into a disposable mouthpiece that is connected to a monitor. The device can be delivered to Canada in a few days. “This portable device, while doing complex things, is simple to operate,” Dr. ...
To date, Okami has developed the LOBO™ Vascular Occlusion System, which is uniquely designed to provide interventional physicians with a single-device, one-and-done solution for the occlusion of a wide range of arterial targets without the need for multiple embolic devices. ...
Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma. ...
The LOBO (LOw-profile Braided Occluder) system is uniquely designed to provide interventional physicians with a single-device, one-and-done solution for the occlusion of various arterial targets without the need for multiple embolic devices. ...
The LOBO system combines a patented design with proprietary HDBRAID™ technology to provide interventional physicians with a minimally invasive platform for rapid and focal occlusion of a wide range of arterial targets with a single device. The LOBO occluder is a low-profile embolic device that is microcatheter compatible for smooth ...
“We are pleased to continue to work with investors who have supported us to build previous successful companies, including Inari Medical Inc. (developing interventional devices for the treatment of pulmonary embolism and deep vein thrombosis), Sequent Medical Inc. (the developer of the WEB Aneurysm Embolization Device, ...